2015 Big Pharma Outlook.
By Ali Al-Bazergan, Lead Analyst
16 July 2015
I am the Lead Analyst of the company analysis team at Datamonitor Healthcare, based in the London office. I focus on tra...
Read full bio
Allow me to introduce one of our most anticipated reports this year, the 2015 Big Pharma Outlook. This report allows you to examine and analysis market dynamics that the Big Pharma peer set will have to face up until 2024.
Big Pharma is poised for growth due to strong launch portfolios, the availability of high-potential pipeline assets, and companies’ sharpened focus on high performing markets. By delving deeper into drivers of strategy, revenue trends, and therapy area focus, this analysis is vital to understanding how the industry will navigate headwinds in order to steer towards robust growth.
You can purchase the full report here, however you can also download the accompanying product brochure if you’re not quite sure you want to purchase yet. Our brochure will go into what’s covered in this report in more detail, the highlights, as well as key questions answered. You will also be able to see what’s included in the report, and learn a bit more about the author himself. Just fill in the form across the page and you’ll be able to download straight away.
Seen enough? Perfect! Just click on the button below and we’ll take you straight to our report store where you can purchase this report immediately.
Posted in Company analysis.